Robert W. Baird initiated coverage on Privia Health with a new price target
$PRVA
Medical/Nursing Services
Health Care
Robert W. Baird initiated coverage of Privia Health with a rating of Outperform and set a new price target of $23.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/10/2025 | $25.00 | Buy | Needham |
| 12/16/2024 | Outperform | Macquarie | |
| 10/11/2024 | $23.00 | Overweight | KeyBanc Capital Markets |
| 5/30/2024 | $23.00 | Outperform | Robert W. Baird |
| 4/22/2024 | $25.00 | Buy | Citigroup |
| 3/6/2024 | $22.00 | Equal Weight | Barclays |
| 2/26/2024 | $33.00 → $25.00 | Buy | Jefferies |
| 2/22/2024 | $21.00 | Buy → Neutral | BofA Securities |
Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of Range for Practice Collections, GAAP Revenue, Platform Contribution and Adjusted EBITDA c ARLINGTON, Va., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the second quarter ended June 30, 2025. Second Quarter Performance For the Three Months Ended June 30, ($ in millions, except per share amounts) 2025 2024 Change (%) Total revenue $521.2 $422.3 23.4%Gross profit $112.8 $98.3 14.8%Operating income $3.3 $5.1 (34.6)%Ne
ARLINGTON, Va., July 10, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its second-quarter and six-month periods ended June 30, 2025 before market open on Thursday, August 7, 2025. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, August 7, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/eve
ARLINGTON, Va., July 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced the appointment of Lance V. Berberian to its Board of Directors, effective July 15, 2025. He has also been named a member of the Audit Committee of the Board. Following the appointment of Mr. Berberian, the Board will comprise 10 directors. "We are excited to welcome Lance to our Board of Directors," said David King, Chairman of the Board, Privia Health Group, Inc. "Lance brings extensive technology strategy and digital transformation experience to the Board, including IT governance, infrastructure management and cybersecurity. We believe his expertise will be invaluable to Privia Health as
Needham initiated coverage of Privia Health with a rating of Buy and set a new price target of $25.00
Macquarie initiated coverage of Privia Health with a rating of Outperform
KeyBanc Capital Markets initiated coverage of Privia Health with a rating of Overweight and set a new price target of $23.00
4 - Privia Health Group, Inc. (0001759655) (Issuer)
3 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
10-Q - Privia Health Group, Inc. (0001759655) (Filer)
8-K - Privia Health Group, Inc. (0001759655) (Filer)
SCHEDULE 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of Range for Practice Collections, GAAP Revenue, Platform Contribution and Adjusted EBITDA c ARLINGTON, Va., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the second quarter ended June 30, 2025. Second Quarter Performance For the Three Months Ended June 30, ($ in millions, except per share amounts) 2025 2024 Change (%) Total revenue $521.2 $422.3 23.4%Gross profit $112.8 $98.3 14.8%Operating income $3.3 $5.1 (34.6)%Ne
ARLINGTON, Va., July 10, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its second-quarter and six-month periods ended June 30, 2025 before market open on Thursday, August 7, 2025. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, August 7, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/eve
Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged ARLINGTON, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the first quarter ended March 31, 2025. Three Months Ended March 31, ($ in millions, except per share amounts) 2025 2024 Change (%)* Total revenue $480.1 $415.2 15.6%Gross profit $103.6 $93.4 11.0%Operating income $5.2 $0.8 534.0%Net income a $4.2 $3.0 41.4%Non-GAAP adjusted net income b d e $27.8 $22.5 23.3%Net income per share $0.03 $0.02 50.0%Non-GAAP adju
ARLINGTON, Va., July 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced the appointment of Lance V. Berberian to its Board of Directors, effective July 15, 2025. He has also been named a member of the Audit Committee of the Board. Following the appointment of Mr. Berberian, the Board will comprise 10 directors. "We are excited to welcome Lance to our Board of Directors," said David King, Chairman of the Board, Privia Health Group, Inc. "Lance brings extensive technology strategy and digital transformation experience to the Board, including IT governance, infrastructure management and cybersecurity. We believe his expertise will be invaluable to Privia Health as
ARLINGTON, Va., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today. Mr. Fargis will serve as the Company's chief legal officer, working with Privia executive leadership to support the Company's long-term direction and growth. "Ed is a proven leader who brings an invaluable healthcare industry perspective as well as extensive experience managing corporate governance, compliance and strategic transactions," said Parth Mehrotra, CEO, Privia Health. "As Privia continues to grow and our industry evolves, we are fortunate to have Ed joining us
ARLINGTON, Va., April 12, 2023 (GLOBE NEWSWIRE) -- Privia Health (NASDAQ:PRVA), a technology-driven, national physician enablement company, today announced that Parth Mehrotra, currently the Company's President and Chief Operating Officer, has been named Chief Executive Officer, effective July 1, 2023. Mehrotra is succeeding current CEO, Shawn Morris, who is retiring and will remain on the Company's Board of Directors. Under Morris' leadership since early 2018, Privia Health progressed from a private, regional organization into a publicly-traded company with national reach. During that time, the Company entered eight new states, completed a successful IPO in April 2021, and increased it
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)